Introduction {#sec1}
============

Sickle cell disease is a group of hereditary hemolytic anemias, first described in 1910 \[[@cit0001]\], being the most common monogenic hereditary disease in the world. It affects approximately 100,000 individuals in the United States \[[@cit0002]\]. In Brazil, it is estimated that there are 35,000 people living with sickle cell disease (SCD), as a result of slave traffic for more than three hundred years \[[@cit0003]\]. Individuals who are homozygous for the hemoglobin S gene develop sickle cell anemia (SCA). When they are heterozygous for two hemoglobinopathies, they develop other sickle cell diseases (OSCD). Cardiac abnormalities are described in SCA, the most common being those related to pulmonary arterial hypertension and consequent right chamber overload \[[@cit0004]\]. There are also changes in left cavities, with increased left ventricular diameters \[[@cit0005]--[@cit0007]\]. These findings usually are not accompanied by systolic function changes \[[@cit0008], [@cit0009]\]. The prevalence of left ventricle dysfunction in these patients is not estimated by large scale studies \[[@cit0005]--[@cit0009]\].

Left ventricular (LV) systolic dysfunction has been reported in older patients with SCA and is a poor prognostic indicator \[[@cit0009], [@cit0010]\]. Pathophysiology of myocardial dysfunction is uncertain and appears to be multifactorial, involving not only a chronic hyperkinetic state, but also specific changes related to hemoglobinopathies \[[@cit0008]\]. In addition to a reduced amount of hemoglobin, another important element in the pathophysiology of SCA is changes in hemoglobin properties in deoxygenation conditions, which lead to red blood cell shape change and consequent microcirculation obstruction by sickle-shaped red blood cells, as well as interaction with leukocytes leading to local inflammation \[[@cit0009]\]. An intrinsic cardiomyopathy is also involved, even in non-anemic patients \[[@cit0011]\]. Myocardial ischemia or infarction, arrhythmia and sudden death are also described in these patients \[[@cit0012], [@cit0013]\].

New echocardiographic methods have been evaluated \[[@cit0014], [@cit0015]\]. Two-dimensional (2D) systolic strain, recently described in patients 18--40 years of age, did not show changes in this population \[[@cit0016]\]. There are controversial speckle tracking studies in this area, showing abnormalities in children of Tanzania \[[@cit0017]\], and no changes in another study with adults \[[@cit0018]\]. Diastolic function may be impaired early and can even be detected in children \[[@cit0009]\]. Diastolic dysfunction implies poor prognosis, especially when associated with pulmonary hypertension \[[@cit0008], [@cit0009], [@cit0019]\]. It may also be a predictor of future systolic dysfunction \[[@cit0020]\].

The aim of this study was to investigate echocardiographic abnormalities, including two-dimensional strain evaluation, in patients with SCA and compare them to data from patients with OSCD.

Material and methods {#sec2}
====================

The study included 76 outpatients of both genders, with sickle cell disease, aged from 18 to 40 years, who attended at the Department of Hematology of Pedro Ernesto University Hospital of the State University of Rio de Janeiro. Sixty patients were homozygous with SCA and 16 doubly heterozygous, with OSCD (14 patients HbSC and 2 patients HbSD). Exclusion criteria were recent history (less than 3 months) of blood transfusion and painful crisis, report or evidence of hypertension, cardiac arrhythmias, irregular heart rate, moderate or severe valve disease, coronary artery disease, cardiomyopathy, pericarditis, myocarditis or HIV infection.

All of the patients provided signed informed consent and study clarification forms before the study began. This study was approved by the Research Ethics Committee of the Pedro Ernesto University Hospital, under number 231.033, and was conducted in accordance with principles outlined in the Declaration of Helsinki. There is no external source of funding and none of the authors has any conflict of interest to declare.

Clinical evaluation and laboratory tests included measurement of weight and height, and tests for hemoglobin concentration. Transthoracic Doppler echocardiography was performed by the same examiner, using the iE33 system (Philips Medical Systems, MA, USA). Images were stored in digital media and reviewed by a second examiner, both unaware of the patients' group.

M-mode measurements were performed according to the American Society of Echocardiography recommendations \[[@cit0021]\]. LV mass was calculated by the Devereux method. Cavity dimensions and mass were indexed by body surface area calculated by the Dubois formula \[[@cit0021]\]. Two-dimensional parameters were left ventricle systolic and diastolic volumes and ejection fraction by modified Simpson method, right ventricle (RV) systolic and diastolic areas and systolic fractional shortening area, right atrium (RA) systolic area and volume and LA systolic volume by area-length method, LV outflow tract diameter, RV free wall thickness, and LV systolic strain \[[@cit0021], [@cit0022]\].

Left ventricular diastolic function was assessed by pulsed Doppler of the mitral inflow and by tissue Doppler obtained at the lateral and medial border of the mitral and tricuspid annulus in the apical four-chamber view \[[@cit0023]\]. E and A waves velocities, E/A ratio, isovolumetric relaxation time (IVRT) and deceleration time of early LV filling (DTE) in mitral flow were recorded. For right ventricular function, E and A wave velocities from tricuspid flow, right and left outflow tract velocities and integral (TVI) were recorded \[[@cit0024]\].

To estimate pulmonary artery systolic pressure (PASP), pulmonary flow acceleration time and tricuspid regurgitation jet velocity were used \[[@cit0021]--[@cit0025]\]. In order to evaluate RV function, S' peak velocity and the RV myocardial performance index (Tei index) were calculated from the tricuspid annulus tissue Doppler image (TDI); moreover, the tricuspid annulus peak systolic excursion (TAPSE) was also measured \[[@cit0026]\].

Forty-two patients of our sample were also evaluated with 2D Strain, in which images of the LV in apical four-, two- and three-chamber views were obtained and made suitable for analysis. The left ventricle was divided into 18 segments and 2D LV longitudinal strain was obtained for each segment using a software package (QLAB, Phillips, USA). Longitudinal strain was assessed in all six LV walls in the three apical views, and the average value of each wall on each view and the global strain value were used for comparisons with the controls \[[@cit0016], [@cit0027]--[@cit0029]\].

Statistical analysis {#sec2.1}
--------------------

It was a blinded cross-sectional study, with comparison between SCA and OSCD patients. Statistical analysis was performed with SPSS 18.0 software (IBM, Chicago, IL, USA). Continuous variables were compared between groups (SCA and OSCD) by Student's *t* test. Pearson's correlation coefficients (*r*) were calculated to investigate the association between hemoglobin levels and echocardiographic parameters. *P-*values less than 0.05 were considered significant. The results were expressed as mean ± SD or absolute number (%).

Results {#sec3}
=======

Patients in the SCA group presented significantly lower levels of hemoglobin than the OSCD group (8.45 ±1.49 g/dl in SCA group vs. 11.41 ±0.81 g/dl in OSCD group; *p* \< 0.001) and higher heart rate (78 ±12 bpm in SCA group vs. 70 ±13 bpm in OSCD group; *p* = 0.049). Median age and body surface area were similar between groups. Forty-six (60.5%) patients were treated with hydroxyurea (44 SCA patients and 2 OSCD patients). Moreover, 5 (6.58%) patients were treated with an antihypertensive (angiotensin-converting enzyme inhibitor), all from the SCA group. Clinical parameters are presented in [Table I](#t0001){ref-type="table"}.

###### 

Clinical characteristics of the groups

  Parameter             SCA (*n* = 60)   OSCD (*n* = 16)   *P*-value
  --------------------- ---------------- ----------------- -----------
  Age \[years\]         26 ±8            25 ±6             0.658
  Male gender           27 (45%)         7 (43.8%)         0.931
  Afrodescendant        60 (100%)        14 (100%)         1.000
  BSA \[m²\]            1.66 ±0.16       1.72 ±0.22        0.338
  Hemoglobin \[g/dl\]   8.45 ±1.49       11.42 ±0.81       \< 0.001
  HR \[bpm\]            77 ±12           70 ±13            0.049
  SBP \[mm Hg\]         121.1 ±12.2      116.0 ±7.61       0.114
  DBP \[mm Hg\]         76.5 ±11.7       72.1 ±9.10        0.204

Values are expressed as means ± SD or number (%). BSA -- body surface area, HR -- heart rate, bpm -- beats per minute, SBP -- systolic blood pressure, DBP -- diastolic blood pressure.

Echocardiographic parameters obtained by M-mode and two-dimensional echocardiography ([Table II](#t0002){ref-type="table"}) showed significant enlargement of left cavity dimensions in SCA patients, but no change in ejection fraction obtained either by Teichholz or Simpson methods. LV and RV systolic function data were normal in all patients.

###### 

Echocardiographic M-mode and two-dimensional parameters

  Parameter            SCA (*n* = 60)   OSCD (*n* = 16)   *P*-value
  -------------------- ---------------- ----------------- -----------
  LAi \[cm/m²\]        2.58 ±0.32       2.25 ±0.28        \< 0.001
  LAVi \[ml/m²\]       47.7 ±11.5       31.7 ±8.42        \< 0.001
  LVDDi \[cm/m²\]      3.47 ±0.37       2.97 ±0.41        \< 0.001
  LVSDi \[cm/m²\]      2.12 ±0.31       1.86 ±0.28        \< 0.001
  LVDVi \[ml/m²\]      77.9 ±17.2       60.7 ±15.4        0.001
  LVSVi \[ml/m²\]      31.6 ±7.70       24.1 ±6.60        0.001
  FE Teicholz (%)      68.2 ±6.69       67.1 ±6.21        0.527
  FE Simpson (%)       59.6 ±4.20       60.9 ±3.36        0.220
  LVMi \[g/m²\]        106.5 ±23.2      75.19 ±20.1       \< 0.001
  RAVi \[ml/m²\]       31.8 ±7.75       25.6 ±5.24        0.002
  RV diameter \[cm\]   2.23 ±0.52       2.23 ±0.59        0.919
  TAPSE \[cm\]         2.77 ±0.43       2.41 ±0.40        0.004

Values are expressed as means ± SD. LAi -- left atrial diameter index, LAVi -- left atrial volume index, LVDDi -- left ventricle diastolic diameter index, LVSDi -- left ventricle systolic diameter index, LVDVi -- left ventricle diastolic volume index, LVSVi -- left ventricle systolic volume index, EF -- ejection fraction, LVMi -- left ventricular mass index, RAVi -- right atrium volume index, RV -- right ventricle, TAPSE -- tricuspid annulus peak systolic excursion.

Diastolic function evaluated by E/A ratio, IVRT and DTE was normal in all patients; however, when evaluated by E/e' ratio it was abnormal (\> 8) \[[@cit0024]\] in 35% of SCA patients and 6.3% of OSCD patients (*p* = 0.002) ([Table III](#t0003){ref-type="table"}). The E/e' was higher in the SCA group (7.72 ±1.54 in SCA group vs. 6.70 ±1.65 in OSCD group; *p* = 0.047). E and A wave velocities were greater in the SCA group ([Table III](#t0003){ref-type="table"}). Changes in right cavity flow were detected with higher systolic blood pressure values of pulmonary artery and tricuspid regurgitant jet velocity in the SCA group. The S' wave tissue Doppler velocity at the tricuspid annulus was significantly higher in the SCA group. The cardiac index calculated from the LV outflow tract was significantly higher in the SCA group (4.01 ±1.10 l/min/m² in SCA group vs. 2.96 ±0.59 l/min/m² in OSCD group; *p* \< 0.001).

###### 

Doppler echocardiographic parameters

  Parameter                SCA (*n* = 60)   OSCD (*n* = 16)   *P-*value
  ------------------------ ---------------- ----------------- -----------
  Mitral E wave \[m/s\]    1.10 ±0.18       0.97 ±0.18        0.021
  Mitral A wave \[m/s\]    0.62 ±0.12       0.51 ±0.12        0.003
  E/A ratio                1.80 ±0.33       1.97 ±0.50        0.213
  Lateral e\'              16.63 ±3.42      17.17 ±2.68       0.525
  Septal e\'               12.05 ±2.02      12.73 ±1.81       0.232
  E/e\' ratio              7.72 ±1.54       6.70 ±1.65        0.047
  Abnormal E/e\' ratio     21 (35%)         1 (6.3%)          0.002
  IVRT \[ms\]              70.6 ±15.0       65.0 ±10.0        0.201
  DTE \[ms\]               160 ±15          175 ±23           0.069
  Tricuspid S\' \[cm/s\]   17.2 ±3.01       14.8 ±2.42        0.002
  TR velocity \[m/s\]      2.52 ±0.35       2.09 ±0.18        \< 0.001
  PASP \[mm Hg\]           30.2 ±7.15       22.1 ±4.52        \< 0.001
  AT \[s\]                 148 ±29          144 ±23           0.581
  RVMPI                    0.31 ±0.05       0.30 ±0.06        0.791

Values are expressed as means ± SD or number (%). Mitral E wave -- E wave maximum velocity at mitral inflow, Mitral A wave -- A wave maximum velocity at mitral inflow, E/A ratio -- ratio between the E and A wave velocities in the mitral flow, Lateral e' -- e' wave velocity at lateral mitral annulus, Septal e' -- e' tissue Doppler image velocity on septal mitral annulus, E/e' ratio -- ratio between mitral E wave and mean mitral annulus e' wave velocities, Tricuspid S' -- S' wave tissue Doppler velocity at lateral tricuspid annulus, TR velocity -- tricuspid regurgitation maximum velocity, PASP -- pulmonary artery systolic pressure, AT -- pulmonary flow acceleration time, RVMPI -- RV myocardial performance index.

There were no differences between groups in two-dimensional LV strain values evaluation, as shown in [Table IV](#t0004){ref-type="table"}. Assuming as a normal range value less than --18.9 \[[@cit0022]\], we found no differences between groups comparing the frequency of abnormal LV strain results.

###### 

Two-dimensional left ventricular strain echocardiographic parameters

  Parameter                                  SCA(*n* = 28)   OSCD(*n* = 16)   *P*-value
  ------------------------------------------ --------------- ---------------- -----------
  X 4C                                       --17.14 ±2.77   --17.64 ±3.08    0.357
  X 3C                                       --18.29 ±3.26   --19.00 ±2.48    0.624
  X 2C                                       --17.85 ±3.08   --16.29 ±2.27    0.111
  S Global                                   --17.85 ±1.53   --17.64 ±1.86    0.849
  S Global ≥ --18.9                          13 (79%)        7 (50%)          0.418
  Age \[years\][\*](#tf4-1){ref-type="fn"}   24 ±6           26 ±6            0.170
  Male gender[\*](#tf4-1){ref-type="fn"}     14 (50%)        5 (35%)          0.392

Values are expressed as means ± SD or number (%). X 4C -- 4-chamber longitudinal strain, X 3C -- 3-chamber longitudinal strain, X 2C -- 2-chamber longitudinal strain, X Global -- left ventricular global longitudinal strain.

Calculated in the sample evaluated for 2D strain.

Significant correlations were detected between hemoglobin levels and left ventricular diameters and mass indexes, left atrial volume index and mitral A wave velocity. [Table V](#t0005){ref-type="table"} shows correlations between hemoglobin levels and echocardiography parameters.

###### 

Correlations between hemoglobin levels and echocardiography parameters

  Parameter       *r*       *P-*value
  --------------- --------- -----------
  LVDDi           --0.594   \< 0.001
  LVSDi           --0.465   \< 0.001
  LVEF            --0.037   0.820
  LVMi            --0.491   0.001
  LAVi            --0.637   \< 0.001
  LVGX            0.075     0.641
  Mitral E wave   --0.276   0.085
  Mitral A wave   --0.340   0.032
  E/A ratio       0.212     0.190
  Septal e\'      0.043     0.799
  Lateral e\'     --0.069   0.680
  E/e\' ratio     --0.164   0.333

LVDDi -- left ventricle diastolic diameter index, LVSDi -- left ventricle systolic diameter index, LVEF -- left ventricle ejection fraction, LVMi -- left ventricle mass index, LAVi -- left atrial volume index, LVGX -- left ventricle global strain, Mitral E wave -- E wave maximum velocity at mitral inflow, Mitral A wave -- A wave maximum velocity at mitral inflow, E/A ratio -- ratio between the E and A wave velocities in the mitral flow, Septal e' -- e' tissue Doppler image velocity on septal mitral annulus, Lateral e' -- e' wave velocity at lateral mitral annulus, E/e' ratio -- ratio between mitral E wave and mean mitral annulus e' wave velocities.

Discussion {#sec4}
==========

Cardiac abnormalities in patients with sickle cell anemia have been previously described \[[@cit0030]--[@cit0033]\]. Adaption to anemia states, where oxygen-carrying capacity to tissues is reduced, involves a rise in cardiac output. This was corroborated by a significant increase in cardiac index in our SCA patients, who have lower hemoglobin levels than the OSCD group. Left ventricular dilatation and eccentric hypertrophy found in these patients appear to be due to adaptation to the hyperkinetic state imposed by anemia \[[@cit0006], [@cit0007], [@cit0034]\]. Besides this, the right heart changes, mainly related to pulmonary hypertension, are well described.

In our study, the main focus was the evaluation of left heart chambers. A pertinent question is whether the left cavity dilation is exclusively secondary to the hyperkinetic state or is also related to structural histology changes in the myocardium. In our sample, the left cardiac chambers' size and mass correlated negatively with hemoglobin levels, favoring the first hypothesis. The presence of diastolic dysfunction points to this second hypothesis, but it was not proven regarding the systolic function. Two mechanisms have been postulated for development of diastolic dysfunction: microcirculatory obstruction and myocardial iron deposit, in patients receiving multiple transfusions \[[@cit0009]\]. Nevertheless, a study of cardiac magnetic resonance, measuring myocardial iron deposits, found no correlation with diastolic dysfunction \[[@cit0035]\]. One limitation of studies of left cavities in SCA patients is to compose a control group with similar levels of hemoglobin to overcome the hemodynamic effects of anemia. In our sample, the E/e' ratio was greater in the SCA group. However, this can be explained for the hyperkinetic state because mitral E wave velocity was also greater in this group. In our sample, additionally, mitral A wave correlated significantly with hemoglobin levels.

We found no comparisons of echocardiography parameters in patients with SCA and OSCD in the literature. Our results in the SCA group were similar to other reports which showed left atrial and ventricular dilatation with preserved systolic function indexes in patients with SCA. higher values of E/e' ratio were observed in the SCA group, which does not necessarily represent diastolic dysfunction. Indeed, these results indicate a possible influence of hyperkinetic state leading to increased E wave velocity values. Sachdev *et al.* \[[@cit0019]\] reported a prevalence of 18% for diastolic dysfunction in SCA patients, but using the E/A ratio as the criterion. Tissue Doppler velocities must be more accurate for evaluation of diastolic function in SCA patients.

Regarding two-dimensional LV strain, there were no differences between groups and no correlation with hemoglobin levels. Our findings were similar to the study of Barbosa *et al.* \[[@cit0016]\], where strain changes in these patients were not detected, evaluating the same age range. The variability of normality criteria assumed by different authors makes the strain analysis difficult \[[@cit0027]\]. Depending on the reference values some patients may be classified as normal or abnormal. Speckle tracking study results were ambiguous, with change in a study of children in Tanzania and normal results in another study in Arabia \[[@cit0018]\]. These controversial results must be related to differences in technical issues between studies or different evolution of disease in underdeveloped countries and point to the need of additional studies with left ventricular strain. We believe that studies with older patients will show any change caused by progressive microcirculatory ischemic changes in the myocardium.

With respect to the right chambers, higher levels of PASP and tricuspid regurgitation jet velocity in patients with SCA were detected. Interestingly, the S' wave tissue Doppler velocity and TAPSE were significantly higher in this group of patients. Although not previously described, these indexes may have been influenced by the hyperkinetic state imposed by anemia. The RV myocardial performance index showed no changes in our sample. Caldas showed that this index may be an early indicator of diastolic dysfunction \[[@cit0036]\].

The strength of the current study is that it is the first to compare the ventricular function and chamber dimensions and volumes between patients with SCA and patients with OSCD. We consider the small sample size to be the main limitation of our study, especially the small number of patients in the OSCD group. However, we believe that our results justify further research on the use of echocardiographic parameters as markers of severity in patients with sickle cell disease because they can be important in the follow-up of these patients.

In conclusion, there was an increase of left and right cavity dimensions in SCA patients compared to OSCD patients, without changes in systolic function in both groups in our sample. We found no differences in LV longitudinal two-dimensional strain analysis between groups. Furthermore, we found that the E/e' ratio is higher in SCA patients compared to OSCD patients, which may be due to the hyperkinetic state because the values of the mitral E wave velocity were also higher in this group. Future prospects can compare the LV function and two-dimensional strain parameters in patients with similar levels of hemoglobin with or without SCA, to abrogate the impact of the hyperkinetic state of anemia and in older patients, assuming that systolic changes could appear later in the course of the disease.
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